Skip to main content

AbbVie Inc. (NYSE: ABBV) Investor Files Securities Class Action Lawsuit 06/04/2022

  • If you purchased a significant amount of shares of AbbVie Inc. (NYSE: ABBV) between April 30, 2021, and August 31, 2021, and / or if you purchased any NYSE: ABBV shares prior to April 2021, and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: JUNE 6, 2022. NYSE: ABBV investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

February 16, 2023 - The case was voluntarily dismissed. April 6, 2022 - An investor in shares of AbbVie Inc. (NYSE: ABBV) filed a lawsuit in the U.S. District Court for the Northern District of Illinois over alleged violations of Federal Securities Laws by AbbVie Inc. in connection with certain allegedly false and misleading statements made between April 30, 2021, and August 31, 2021....

You must register (for free) or login to view the entire case.